The CSF1 receptor inhibitor pexidartinib (PLX3397) reduces...

  • Main
  • 2019 / 3
  • The CSF1 receptor inhibitor pexidartinib (PLX3397) reduces...
International Journal of Obesity 2019 / 3

The CSF1 receptor inhibitor pexidartinib (PLX3397) reduces tissue macrophage levels without affecting glucose homeostasis in mice

Merry, Troy L., Brooks, Anna E. S., Masson, Stewart W., Adams, Shannon E., Jaiswal, Jagdish K., Jamieson, Stephen M. F., Shepherd, Peter R.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
International Journal of Obesity
DOI:
10.1038/s41366-019-0355-7
Date:
March, 2019
File:
PDF, 1.01 MB
english, 2019
Conversion to is in progress
Conversion to is failed